RAD51 biomarker could complement next-generation sequencing in personalizing prostate cancer treatment
Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...
MedPage Today12h
Thyroid Cancer Still Overdiagnosed in the U.S., Study Finds
Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to ...
The Lancet11h
Trends in thyroid cancer incidence and overdiagnosis in the USA
In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...
GlobalData on MSN23h
RedHill Biopharma launches trial of combination therapy for prostate cancer
Israeli pharmaceutical company RedHill Biopharma has initiated a placebo-controlled Phase II trial to assess the combination ...